12-4911898-G-T
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_000217.3(KCNA1):c.520G>T(p.Val174Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V174I) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000217.3 missense
Scores
Clinical Significance
Conservation
Publications
- episodic ataxia type 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
 - episodic kinesigenic dyskinesia 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - isolated autosomal dominant hypomagnesemia, Glaudemans typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - genetic developmental and epileptic encephalopathyInheritance: AR, AD Classification: SUPPORTIVE, LIMITED Submitted by: G2P, Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 31 
GnomAD4 exome Cov.: 35 
GnomAD4 genome  Cov.: 31 
ClinVar
Submissions by phenotype
Episodic ataxia type 1    Pathogenic:2 
- -
This sequence change replaces valine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 174 of the KCNA1 protein (p.Val174Phe). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with episodic ataxia (PMID: 2245301, 7842011; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 13482). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt KCNA1 protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
Inborn genetic diseases    Pathogenic:1 
The c.520G>T (p.V174F) alteration is located in exon 2 (coding exon 1) of the KCNA1 gene. This alteration results from a G to T substitution at nucleotide position 520, causing the valine (V) at amino acid position 174 to be replaced by a phenylalanine (F). Based on data from the Genome Aggregation Database (gnomAD), the KCNA1 c.520G> alteration was not observed, with coverage at this position. The KCNA1 c.520G>T (p.V174F) alteration was shown to segregate with disease in a large pedigree; samples were available from 18 affected family members and 34 unaffected family members (Browne, 1994). The p.V174 amino acid is conserved in available vertebrate species. Functional analysis demonstrated when the V174F alteration was introduced in to Xenopus oocytes, no functional homomeric channels were formed; when introduced with wild-type, almost no current was produced (Adelman, 1995). In a later study, also using Xenpus oocytes, it was shown that V174F shifted the voltage dependence of activation to more positive potentials (Zerr, 1998). The p.V174F alteration is predicted to be probably damaging by Polyphen and deleterious by SIFT in silico analyses. Based on the available evidence, this alteration is classified as pathogenic. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at